The CDC has revised its COVID-19 vaccine recommendations following FDA regulatory action, allowing for an additional updated vaccine dose for adults aged 65 years and older, and multiple doses for those who are immunocompromised.
The CDC’s announcement also simplifies vaccination schedules to allow bivalent vaccines to be used for primary vaccination series, as well as boosters.